GMR Solutions 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- GMR completed 1.4 million patient encounters in the 3rd quarter of 2026, including over 1.35 million ground patient encounters and nearly 38,000 air medical patients.
- Q3 revenue increased 5.9% to $1.6 billion, adjusted EBITDA increased 4.2% to $357 million, and adjusted EBITDA margin was 22.3%.
- Net income was $135.6 million, compared with $74.6 million in the prior year period; adjusted diluted EPS was $0.64 on approximately 242.4 million diluted weighted average common shares outstanding.
- Same-market revenue increased $88.7 million, or 6% year over year, and new-market revenue contributed $28.2 million.
- Emergent ground transports increased 3.4%, non-emergent ground transports decreased 1.0%, air demand increased 2.8%, and total patient encounters in emergent transports and nurse navigation grew 4.4%.
- Net transport revenue per ambulance transport increased 3.0%; this was supported by positive service mix and underlying improvements, and partially offset by an approximately $16 million payer mix impact from the expiration of Affordable Care Act exchange subsidies.
- Prior-year results benefited from favorable revenue estimate adjustments related to No Surprises Act collections; Q3 2026 changes in estimates were $18 million, approximately $37 million lower than in the prior year period.
- Total operating expense increased 3.4% to $1.33 billion; employee wages, benefits, and taxes increased 3.6% to $802 million, while maintenance, fuel, and other direct expenses increased 25.1% to $150 million.
- GMR generated approximately $110 million of free cash flow, finished the quarter with $298 million in cash and cash equivalents, and had an undrawn ABL with $701 million of cash borrowing capacity after letters of credit.
- GMR repaid approximately $200 million of term loan borrowings, reducing outstanding principal to approximately $2.7 billion, and repriced the facility by 50 basis points; the combined actions are expected to generate approximately $28 million of annual cash interest expense savings.
- Net leverage was 3.4 times, down from 4.3 times at the end of 3Q last year.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Hello, everyone. Thank you for joining us, and welcome to the GMR Solutions Q3 2026 earnings call. After today's prepared remarks, we will host a question-and-answer session. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again. I will now hand the conference over to Krister Sorensen, Vice President of Investor Relations. Krister, please go ahead. Thank you.
Good morning, and welcome to the GMR Solutions Q3 2026 earnings conference call. Joining me today are Nick Loporcaro, our Board Chair and CEO, Ted Van Horne, our President and COO, and Brian Tierney, our Executive Vice President and CFO. Before we begin, note that during this call, we may make forward-looking statements, and actual results may differ materially from those statements because of various risks and uncertainties, including those described in our most recent earnings report posted on our investor relations website and in the risk factors section of our IPO prospectus. Today's remarks also include certain non-GAAP financial measures, including Adjusted EBITDA, adjusted diluted EPS, and free cash flow. You can find a reconciliation of these measures in our earnings release and earnings presentation that is available on our website at investors.globalmedicalresponse.com.
Unless otherwise noted, references to the quarter will be for the third quarter of 2026. I will now turn the call over to Nick.
Thanks, Krister, and thank you all for joining us today. We are pleased to be reporting continued solid results for the third quarter, with revenue, Adjusted EBITDA, and free cash flow all increasing year-over-year. Core emergent demand remained healthy, and disciplined execution helped us manage a more challenging fuel and inflation environment. That said, before we discuss our results, I want to take a moment to remember two of our team members and a patient that tragically lost their lives in a rotor accident off Catalina Island on September 30, along with one of our team members and the patient's attendant who survived the accident. We are cooperating fully with the FAA and NTSB as they investigate the cause. Our thoughts and prayers remain with the families, our team members, and everyone impacted by this tragedy.
This is a somber reminder that the work our teams perform every day is mission-critical and, by its nature, carries inherent risk. Safety remains fundamental to how we operate, and we remain committed to identifying, managing, and mitigating those risks. Now, let me turn to our third-quarter results. GMR completed 1.4 million patient encounters during the third quarter. We provided ground medical services to over 1.35 million patients, which included more than 1 million transports, along with 32,000 calls through our 911 Nurse Navigation offering, and the remaining approximately 280,000 ground patient encounters consisted of interventions on scene that did not result in a transport. During the quarter, we provided air medical services to nearly 38,000 patients. Q3 revenue increased 5.9% to $1.6 billion. Adjusted EBITDA increased 4.2% to $357 million, with an Adjusted EBITDA margin of 22.3%.
As with last quarter, this quarter's prior year results benefited from favorable revenue estimate adjustments associated with No Surprises Act-related collections on claims from earlier dates of service. Despite this comparability impact, the business delivered strong revenue growth and increased Adjusted EBITDA. Favorable service mix and disciplined cost management helped mitigate fuel and other inflationary pressures. The quarter also highlighted the benefits of our national platform and integrated services. We operate across air and ground services, diverse geographies, and a broad range of community and health system relationships. This breadth helps us manage variability in any individual service line or market while continuing to deploy our clinical capabilities where they create the greatest value. We remain focused on executing against our four strategic priorities: clinical excellence, growth, differentiation, and sustainable margins.
Recall that we are the largest provider of emergency medical services in the country, serving approximately 5.5 million patients annually in markets representing more than 60% of the U.S. population. With more than 24,000 highly trained clinicians and a fleet of ambulances and aircraft, we have the scale and capabilities to deliver critical care to patients when and where they need it most. On the reimbursement front, we continue to make progress in pursuing in-network and preferred provider agreements with payers willing to engage at appropriate rates and terms. When payers do not engage, we assert our right to be paid appropriately for the out-of-network emergency services we deliver. This includes working with state regulators when we see patterns of health plans inappropriately denying coverage of urgent and medically necessary care, as well as filing claims under the federal No Surprises Act whenever warranted.
As Congress considers reforms to the No Surprises Act, we are confident that most policymakers understand the need to preserve an arbitration process for emergency services. We are also gratified by the growing consensus that any reforms need to include a strong and meaningful enforcement mechanism to ensure that health plans pay arbitration awards on a timely basis. We will continue to educate federal and state policymakers, policy influencers, and the media to make the case for reforms that protect patients while also ensuring fair payment for emergency services, even when those services are out of network. We are pleased with the underlying demand and execution reflected in the quarter, while recognizing that elevated fuel and other inflationary pressures will remain important considerations as we enter 2027. Our focus remains on disciplined execution, targeted growth, and actions that support sustainable long-term value creation.
I'll now turn it over to Ted to provide an operational update.
Thanks, Nick. Our operational focus remains straightforward. Grow our core emergent services, participate selectively in non-emergent services where they make strategic and economic sense, and use innovation to deliver care more efficiently. The advantage of our integrated model is our ability to coordinate care across modalities and geographies, rather than operating each service independently. That allows us to better match clinical resources to patient needs, improve efficiency, and provide broader solutions to our community and health system partners. A great example of this is our 911 Nurse Navigation solution. During the quarter, Nurse Navigation supported over 32,000 calls across 30 communities, representing over 19 million covered lives. This represents a 51% increase in call volume over the prior year quarter. We continue to see strong potential to expand Nurse Navigation within existing markets and to use it as a differentiator as we pursue new municipal and health system partnerships.
Turning to growth, we continue to see opportunities across both existing and new markets. Same-market revenue increased $88.7 million, or 6% year over year, while new market revenue contributed $28.2 million during the quarter. We launched three new 911 systems, two new air bases, and one new inter-facility market in the quarter. We also executed new agreements totaling over $50 million in incremental annualized revenue. We continue to prioritize opportunities where integrated capabilities provide an advantage and where the economics support sustainable long-term partnerships. Beyond these near-term wins, our scale creates additional opportunities to deploy clinical resources where they are needed, respond quickly to surges in demand, and support customers and communities in line with our core business.
While we did not have a FEMA hurricane deployment this year, our teams remained highly active across a range of events and emergency response needs, demonstrating the breadth of our capabilities beyond any single type of deployment. At the 2026 FIFA World Cup, GMR provided medical services at seven of the 11 U.S. host locations, caring for over 3,100 patients, including 200 who were transported to area hospitals. During the 4th of July holiday week, we rapidly expanded capacity in New York City, deploying 50 additional ambulances and responding to over 2,000 911 calls amidst extreme heat and the 250th anniversary celebrations. When three hurricanes impacted Hawaii, our local and regional teams surged additional personnel and support into the state.
We partnered directly with county emergency operations centers and expanded our air and ground ambulance capacity into the 911 systems to handle the demands the storm caused on the island communities. Similarly, subsequent to the quarter, in early October, we were deployed by the Florida Ambulance Association and HCA for Hurricane Isaias, with 105 ambulances and over 250 personnel brought in to relocate patients to facilities out of the storm's path and provide 911 and rescue support through the storm. Total revenue for this deployment was approximately $4 million. These examples demonstrate operational capability, but they are not the foundation of our growth strategy. Our primary focus remains consistent execution in core markets, expansion of emergent services, and development of scalable solutions that address longer-term gaps in access and capacity.
That includes working with states and communities to improve rural healthcare access through our 911 REACT solution and the Rural Health Transformation Program. Our scale, clinical resources, and integrated model position us to help communities address EMS capacity constraints while creating attractive, sustainable growth opportunities. Overall, we're encouraged by demand across the platform and the progress we are making in NurseNav, core emergent services, and new market development. At the same time, we remain disciplined about contract economics, resource deployment, and the pace of expansion. With that, I'll turn it over to Brian to discuss our financial performance in more detail.
Thanks, Ted. In the third quarter of 2026, GMR delivered solid financial performance in a challenging operating environment. Net revenue increased 5.9% to $1.6 billion, supported by healthy demand in our core emergent services, continued improvement in net revenue per transport, and contributions from new markets. Compared to the same quarter in 2025, emergent ground transports increased 3.4%, driven by strong same-store demand, while non-emergent ground transports decreased 1.0%, reflecting our deliberate strategy of redirecting our resources towards higher acuity responses. Air demand increased 2.8%. However, transports were essentially flat, driven by decreased capture rate, primarily from worse weather compared to the prior year quarter. As a result, during the quarter, total patient encounters associated with our focus areas of emergent transports and NurseNav grew 4.4%, while lower reimbursement patient encounters associated with non-emergent wheelchair and non-transports decreased 4.2%.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
11 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
